Newgenivf Group Limited's ability to collect accounts receivable sequentially worsen to 27.02, indicating more challenging environment then in the third quarter 2025, but still, it is a far cry from any concerns. Newgenivf Group Limited's Accounts Receivable average collection period in the Dec 31 2025 quarter, has increased to 14 days, from 12 days, in the 0 quarter.

If we take a look into Healthcare sector 54 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from to 574.

What is Receivable Turnover Ratio?
What is Newgenivf Group Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NIVF Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	17.1 %	393.75 %	-54.21 %	-54.21 %	-53.04 %
Y / Y Revenue Change	-7.98 %	-	-	-	-
Receivable Turnover Ratio (TTM)	27.02	30.65	38.22	27.96	22.05
NIVF's Total Ranking	# 574	#	#	#	#
Accounts Receivable average collection period days	14	12	10	13	17
Seq. Receivable Change	20.08 %	0 %	0 %	-2.49 %	406.34 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 6
Healthcare Sector	# 55
Overall Market	# 574

Receivable Turnover Ratio Statistics
High	Average	Low
27.02	20.57	14.12
(Dec 31 2025)		(Dec 31 2023)

NIVF Company Profile • Back to NIVF Efficiency Comparisons • Compare NIVF Receivables Turnover Ratio to its Competitors

Financial Statements
Newgenivf Group Limited's Accounts Receivable	$ 0 Millions	Visit NIVF's Balance sheet
Newgenivf Group Limited's Sales TTM	$ 5 Millions	Visit NIVF's Income Statement
Sources of NIVF's Revenues		Visit NIVF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NIVF's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NIVF's Growth Rates	NIVF's Roa	NIVF's Inventory Turnover Ratio	NIVF's Dividend Comparisons
NIVF's Profitability Ratios	NIVF's Roi	NIVF's Asset Turnover Ratio	NIVF's Dividend Growth
NIVF's Valuation Ratios	NIVF's Roe	NIVF's Financial Strength Ratios	NIVF's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Airsculpt Technologies Inc	59.97	$ 151.818 Millions	$ 2.532 Millions
Spero Therapeutics Inc	56.29	$ 66.802 Millions	$ 1.187 Millions
Crinetics Pharmaceuticals Inc	52.00	$ 7.696 Millions	$ 0.148 Millions
Brookdale Senior Living Inc	51.27	$ 3,194.066 Millions	$ 62.298 Millions
Eyepoint Inc	45.42	$ 31.371 Millions	$ 0.691 Millions
X4 Pharmaceuticals Inc	45.05	$ 35.113 Millions	$ 0.780 Millions
Fortrea Holdings Inc	44.55	$ 2,723.400 Millions	$ 61.125 Millions
Longduoduo Co Ltd	44.55	$ 2.722 Millions	$ 0.061 Millions
Lifevantage Corp	44.29	$ 208.401 Millions	$ 4.705 Millions
Valion Bio Inc	42.84	$ 0.482 Millions	$ 0.011 Millions
Kyntra Bio Inc	41.55	$ 6.440 Millions	$ 0.155 Millions
Cytomx Therapeutics Inc	40.82	$ 76.201 Millions	$ 1.867 Millions
Solana Company	40.38	$ 6.017 Millions	$ 0.149 Millions
Atara Biotherapeutics Inc	40.31	$ 121.355 Millions	$ 3.010 Millions
Nature s Sunshine Products inc	39.85	$ 479.724 Millions	$ 12.040 Millions
National Vision Holdings Inc	39.24	$ 1,987.488 Millions	$ 50.646 Millions
Lineage Cell Therapeutics Inc	39.16	$ 14.556 Millions	$ 0.372 Millions
Monte Rosa Therapeutics Inc	37.07	$ 123.672 Millions	$ 3.336 Millions
Meiragtx Holdings Plc	36.74	$ 81.391 Millions	$ 2.215 Millions
Protagonist Therapeutics inc	35.26	$ 46.016 Millions	$ 1.305 Millions
Stoke Therapeutics Inc	35.18	$ 184.420 Millions	$ 5.243 Millions
Agenus Inc	32.27	$ 114.196 Millions	$ 3.539 Millions
Metagenomi Therapeutics Inc	32.01	$ 25.210 Millions	$ 0.788 Millions
U S Physical Therapy Inc	30.83	$ 780.990 Millions	$ 25.331 Millions
Invo Fertility Inc	30.16	$ 6.841 Millions	$ 0.227 Millions
Innovative Eyewear Inc	28.53	$ 2.662 Millions	$ 0.093 Millions
Aesthetic Medical International Holdings Group Limited	28.50	$ 106.636 Millions	$ 3.742 Millions
Puretech Health Plc	28.24	$ 4.659 Millions	$ 0.165 Millions
Newgenivf Group Limited	27.02	$ 4.726 Millions	$ 0.175 Millions
Evotec Se	26.89	$ 882.978 Millions	$ 32.835 Millions

Date modified: 2026-09-02T16:46:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.